In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synecor LLC

www.synecor.com

Latest From Synecor LLC

The J&J Lesson

J&J's exit from the coronary angioplasty market was a sign of the end of an era. Without a product at the high end of innovation, it was left with a basic product that in the interim had become commoditized.

Medical Device

Percutaneous Intravascular Defibrillator Could Avert Common ICD Complications

A percutaneous intravascular cardioverter-defibrillator matched a conventional ICD in a randomized comparison of defibrillation thresholds. The authors of the study believe the PICD could reduce many of the complications associated with conventional defibrillators.

Medical Device Innovation

Proving Device Incubation Works: An Interview with The Foundry

A decade ago, incuabators were seen as the best medicine for what then ailed the medical device industry, most notably a complex regulatory pathway and a difficult venture financing climate. Perhaps not surprisingly, as both the regulatory path and venture financing grew easier in the mid 2000s, incubators began to struggle, victims of their own financing problems. More recently, two huge acquisitions, Abbott's purchase of Evalve and Medtronic's of Ardian, suggest that at least one incubator, The Foundry, is proving that incubation works.
Medical Device Business Strategies

At PCR, Valves Steal The Show, But DES Shine

Every year for just about the past decade, drug-eluting stents dominated the agenda at the Paris Course on Revascularization and just about any meeting where interventional cardiologists gathered to hear the latest in technology and practice innovation. But without question, the star of this year’s PCR was percutaneous heart valves and, in particular the revolution in transaortic valve replacement that has been ushered in by Edwards Lifesciences., which acquired Percutaneous Valve Technologies several years ago, and Medtronic., as a result of its more recent CoreValve acquisition.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Synecor LLC
  • Senior Management
  • William N Starling, CEO
    Richard Stack, MD, Pres.
    Michael Williams, CTO
  • Contact Info
  • Synecor LLC
    Phone: (919) 541-9977
    3908 Patriot Drive
    Ste. 170
    Durham, NC 27703
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register